CN111631404A - Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof - Google Patents
Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof Download PDFInfo
- Publication number
- CN111631404A CN111631404A CN202010539741.2A CN202010539741A CN111631404A CN 111631404 A CN111631404 A CN 111631404A CN 202010539741 A CN202010539741 A CN 202010539741A CN 111631404 A CN111631404 A CN 111631404A
- Authority
- CN
- China
- Prior art keywords
- oil
- vitamin
- food
- fat
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019482 Palm oil Nutrition 0.000 title claims abstract description 59
- 239000002540 palm oil Substances 0.000 title claims abstract description 59
- 239000003921 oil Substances 0.000 title claims abstract description 51
- 235000019198 oils Nutrition 0.000 title claims abstract description 51
- 229940088594 vitamin Drugs 0.000 title claims abstract description 48
- 229930003231 vitamin Natural products 0.000 title claims abstract description 48
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 48
- 239000011782 vitamin Substances 0.000 title claims abstract description 48
- 239000002131 composite material Substances 0.000 title claims abstract description 40
- 239000000944 linseed oil Substances 0.000 title claims abstract description 40
- 235000021388 linseed oil Nutrition 0.000 title claims abstract description 40
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 27
- 235000015097 nutrients Nutrition 0.000 title claims description 18
- 238000002360 preparation method Methods 0.000 title description 5
- 235000013305 food Nutrition 0.000 claims abstract description 47
- 239000011573 trace mineral Substances 0.000 claims abstract description 44
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 42
- 239000008157 edible vegetable oil Substances 0.000 claims abstract description 40
- 235000016709 nutrition Nutrition 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 42
- 239000011669 selenium Substances 0.000 claims description 42
- 229910052802 copper Inorganic materials 0.000 claims description 40
- 239000010949 copper Substances 0.000 claims description 40
- 239000011701 zinc Substances 0.000 claims description 40
- 229910052725 zinc Inorganic materials 0.000 claims description 40
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 39
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 39
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 39
- 230000002354 daily effect Effects 0.000 claims description 26
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 22
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 22
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 22
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 22
- 239000008158 vegetable oil Substances 0.000 claims description 22
- 235000019155 vitamin A Nutrition 0.000 claims description 22
- 239000011719 vitamin A Substances 0.000 claims description 22
- 229940045997 vitamin a Drugs 0.000 claims description 22
- 229930003316 Vitamin D Natural products 0.000 claims description 17
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 17
- 235000019166 vitamin D Nutrition 0.000 claims description 17
- 239000011710 vitamin D Substances 0.000 claims description 17
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 17
- 229940046008 vitamin d Drugs 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 13
- -1 compound vitamin Chemical class 0.000 claims description 12
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 10
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 230000003203 everyday effect Effects 0.000 claims description 6
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 6
- 239000004570 mortar (masonry) Substances 0.000 claims description 6
- 229910052755 nonmetal Inorganic materials 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 239000012047 saturated solution Substances 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 150000002484 inorganic compounds Chemical class 0.000 claims description 2
- 229910010272 inorganic material Inorganic materials 0.000 claims description 2
- 235000008935 nutritious Nutrition 0.000 claims 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 61
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 61
- 229960004488 linolenic acid Drugs 0.000 abstract description 61
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract description 61
- 201000010099 disease Diseases 0.000 abstract description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 29
- 230000036541 health Effects 0.000 abstract description 19
- 241000711573 Coronaviridae Species 0.000 abstract description 17
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 15
- 206010061218 Inflammation Diseases 0.000 abstract description 14
- 230000004054 inflammatory process Effects 0.000 abstract description 13
- 241000607479 Yersinia pestis Species 0.000 abstract description 10
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 9
- 206010035148 Plague Diseases 0.000 abstract description 9
- 230000035764 nutrition Effects 0.000 abstract description 9
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 7
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 7
- 201000001881 impotence Diseases 0.000 abstract description 7
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 230000000050 nutritive effect Effects 0.000 abstract description 6
- 230000000295 complement effect Effects 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract description 4
- 229960001231 choline Drugs 0.000 abstract description 4
- 230000007547 defect Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 208000004930 Fatty Liver Diseases 0.000 abstract description 3
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 208000010706 fatty liver disease Diseases 0.000 abstract description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 3
- 230000001804 emulsifying effect Effects 0.000 abstract description 2
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 201000005671 spondyloarthropathy Diseases 0.000 abstract 1
- 229940091258 selenium supplement Drugs 0.000 description 41
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 38
- 241000282414 Homo sapiens Species 0.000 description 30
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 28
- 235000020778 linoleic acid Nutrition 0.000 description 28
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 28
- 235000004626 essential fatty acids Nutrition 0.000 description 20
- 235000019197 fats Nutrition 0.000 description 19
- 235000012000 cholesterol Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 206010028980 Neoplasm Diseases 0.000 description 16
- 241000700605 Viruses Species 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 206010039921 Selenium deficiency Diseases 0.000 description 12
- 230000002950 deficient Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000010775 animal oil Substances 0.000 description 9
- 235000021466 carotenoid Nutrition 0.000 description 9
- 150000001747 carotenoids Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 208000007536 Thrombosis Diseases 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 206010035664 Pneumonia Diseases 0.000 description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 231100000517 death Toxicity 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 235000021323 fish oil Nutrition 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 4
- 240000003133 Elaeis guineensis Species 0.000 description 4
- 235000001950 Elaeis guineensis Nutrition 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 235000021313 oleic acid Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000005180 public health Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000003556 vascular endothelial cell Anatomy 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- 206010010957 Copper deficiency Diseases 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 3
- 206010016260 Fatty acid deficiency Diseases 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000021003 saturated fats Nutrition 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 206010002482 Angiosclerosis Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 241000709687 Coxsackievirus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000007466 Male Infertility Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003035 anti-peroxidant effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229940044683 chemotherapy drug Drugs 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- 229940067631 phospholipid Drugs 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 description 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010055114 Colon cancer metastatic Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 208000005102 Kashin-Beck Disease Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 206010038111 Recurrent cancer Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- VSKWIQRKBCVBAG-UHFFFAOYSA-N [Cu].[Zn].[Se] Chemical compound [Cu].[Zn].[Se] VSKWIQRKBCVBAG-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 210000003029 clitoris Anatomy 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000021084 monounsaturated fats Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000006453 vascular barrier function Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A palm oil and linseed oil nutritive oil as both medicine and food as composite vitamin and trace element and its preparing process, which belongs to the field of health, biological medicine, Chinese and Western medicine combination and edible oil nutrition, is used as daily edible oil to overcome the defects of fat-soluble vitamins, trace elements, linolenic acid, phosphatide and choline, automatic balance and strengthening synthesis and metabolism, innovative emulsifying and nutritive dual-purpose agent to make the oil-insoluble trace elements uniformly distributed in the oil history, and has excellent preventing and treating effects on exogenous diseases and inflammations such as spondylopathy, fatty liver diabetes, impotence, cardiovascular and cerebrovascular diseases, global corona virus and germ plague, its capsule is convenient to carry and take, is far superior to GB/T21123 nutritive and strengthened VA nutritive oil only with VA, and accords with the important national policies of health, biological medicine and 'promoting the complementary development of Chinese and Western medicine' and nutritive oil series, no environmental pollution, no water consumption, low energy consumption, low investment, low cost, high price, strong competitiveness and wide market at home and abroad.
Description
The technical field is as follows: the invention belongs to the field of important national policy nutritional edible oil, medicine, food and Chinese medicine combined science and technology and product research and development application.
Background art: it is well established, both in fact and internationally, that diseases caused by essential fatty acid deficiencies can be treated only with essential fatty acids. The essential fatty acid is linoleic acid which is a component that can not be synthesized by human body in the fat of various edible oil (liquid at normal temperature) fat (solid at normal temperature), and is supplied by food, so the name is gained, but in reality, the linoleic acid content of common vegetable oil varieties such as rapeseed oil, soybean oil, peanut oil, corn oil and sunflower oil is generally more than 20-50% and does not lack linoleic acid, even too much, but the linolenic acid content is generally below 0.5-5% (the linolenic acid oil content is the linolenic acid content by subtracting three glycerol molecules). Common and commonly used animal and vegetable oils often do not contain linolenic acid which, while not structurally considered to be an essential fatty acid, has important biological effects in the body such as brain development and vision, epithelial tissue structure and functional maintenance such as skin, and the like, and is in fact extremely deficient in that it must be synthesized by food supplies, especially by mammals, especially the highest ranking mammalian human, and thus should still be considered an essential fatty acid. Common and common vegetable oils such as peanut oil, sunflower seed oil, corn oil, olive oil and the like with large yield and production area are qualified and even high in linoleic acid content but basically do not contain linolenic acid, while sesame oil, soybean oil and the like are qualified in linoleic acid and linolenic acid content, but the former are low in yield, low in resource, expensive and have special odor and taste which are difficult to accept by many people, the latter are mostly transgenic soybean oil with large disputed safety because of improving yield and oil content and resisting diseases and pests, other vegetable oils such as linseed oil, walnut oil, safflower seed oil, perilla seed oil, evening primrose oil and the like are lower in resource, more expensive and difficult to meet the requirements of low-price medicines and daily edible oils or raw materials thereof with extremely large demand and market capacity because the main components of the common and common animal oils such as lard, beef tallow and mutton fat are saturated fatty acid, Contains almost no essential fatty acids, especially linolenic acid, or much less than what is needed and proportioned by human body, for example, lard contains about 70% of unsaturated fatty acid, namely oleic acid, but hardly linoleic acid and linolenic acid, oleic acid is just the main component of fat stored in human body, which causes obesity, the fat stored in human body is metabolized to consume a large amount of essential fatty acid, the main component of beef tallow and mutton fat is saturated fatty acid but not essential fatty acid, namely, linoleic acid and linolenic acid and the amount and proportioned needed by human body, and the metabolism of saturated fatty acid also consumes more essential fatty acid than the above-mentioned oleic acid, fish oil, such as cod liver oil, has excellent content and proportion of unsaturated fatty acid, essential fatty acid, linoleic acid and linolenic acid, but heavy fishy smell and taste, and only seawater fish oil is used, because the fresh water fish oil has only 1/5-14 content and biological effect, the destructive effect and the inoperability of the daily exhausted marine resources and the irreguability of the resources, the high price and the high cost are very obvious, the insurability of the resources supply and the inevitable high price and the high cost of the resources are proved to be very obvious, so that all the animal and vegetable oils can not meet the content of linolenic acid which is more than 5 percent of the health guarantee requirement of the vast population from the aspects of resources and price, and various symptoms of essential fatty acid deficiency, such as obesity, skin allergy, such as pruritus, eczema, running water, infection and the like, even serious diseases, such as hyperlipidemia, hypertension, diabetes, cardiovascular and cerebrovascular diseases, such as coronary heart disease and angiosclerosis, rheumatoid arthritis, ulcerative colitis, psoriasis, chronic renal insufficiency, impotence and the like are proved to be difficult to heal for a long time, and various symptoms or serious diseases of essential fatty acid deficiency, Even aggravate the disease and lose good prevention and cure time, make the treatment and rehabilitation difficult, because the disease caused by the deficiency of essential fatty acid can be prevented and cured only by the essential fatty acid.
The vitamin A, D, E and the carotenoid in the fat-soluble vitamins are beneficial vitamins which are easy to be lacked by human bodies, and the beneficial trace elements of selenium, zinc and copper are also important beneficial trace elements which are easy to be lacked by human bodies. Except that the vegetable oil contains vitamin E and the palm oil contains carotenoid, other vitamins and trace elements are not basically contained in the animal and vegetable oil, and the nutrients are very important and indispensable to human health, but daily food is difficult to meet daily requirement of human body and needs to be compensated, so various health problems such as sub-health and various serious diseases are caused, for example, copper has extremely excellent and rapid killing and disintegration action and efficacy on various germs and viruses causing various diseases including influenza and other coronaviruses, especially on the new coronaviruses around the world, but the daily food contains almost no copper and needs to be compensated in time, the edible oil is almost essential to be consumed by anyone every day and even every meal, other foods cannot be consumed, and the industrialization and commercial rate of the edible oil are extremely high, and a student who is called by a specialist 6-month-2-day expert and opens a scholarly to say that people keep life safety and body health at the first place In this regard, a powerful public health system is constructed, and obviously, food safety and health are the root and platform of the system, so that edible oil, which is a valuable and scarce public health system resource, should be mobilized and used as an excellent carrier and platform for effectively compensating the easy-to-lack and important vitamins and trace elements.
In summary, common and common animal and vegetable oils, i.e. rich and cheap animal and vegetable oils, usually contain no or less essential and essential nutrients such as essential fatty acid linolenic acid, vitamins and trace elements with wide and important biological effects, while essential fatty acid linoleic acid generally does not lack or is too much, so that the nutritional and commercial values of single animal and vegetable oils are low. For example, the Jinlongyu blend oil declared to have the Chinese patent No. ZL201410256274.7 only solves the problem of the proportion of saturated, monounsaturated and polyunsaturated fatty acids, namely 1: 1, the whole linolenic acid content is only 5 percent calculated according to the ingredients and the linolenic acid contained in the proportion, the limit index of 1 g linolenic acid (the linolenic acid content is obtained after three glycerol molecules in the linolenic acid oil molecule are deducted) per day, which is the minimum requirement, of a human body which only can barely meet the WHO requirement, is calculated according to 25 g of edible oil which is recommended by WHO-world health organization, the linolenic acid content of linoleic acid: linolenic acid which is recommended by Chinese Nutrition society and WHO is not reached, the linolenic acid content of which is less than 4-6: 1 is not reached any further, the linolenic acid content of the optimal proportion of linoleic acid to linolenic acid which is considered by experts of Harvard university medical college, the reason that the WHO provides the low linolenic acid is considered that the resource, the content ratio of linoleic acid and linolenic acid is generally and seriously deviated from 25-30: 1, namely the linoleic acid content in the edible oil is seriously excessive, the linolenic acid content is subspecies deficient, the linoleic acid excess can seriously affect the absorption of the linolenic acid, the same enzyme can be converted and absorbed only by competing for the same enzyme due to the same converting enzyme of the linoleic acid excess and the linolenic acid excess, obviously, the linolenic acid with low content is in absolute competition failure disadvantage, so that the linolenic acid which is lacked is further lacked and forms a vicious circle, which becomes a serious nutrition short board of edible oil, the height of which directly determines the health and nutrition level and is a nutrition short board of all people, and the patented product, tuna, also lacks the above-mentioned various vitamins and trace elements and their effects, as will be described in detail in the following objects of the invention and in the main principles and advantages of the invention.
The purpose of the invention is as follows: compared with other linolenic acid oil products with high linolenic acid content, low resource and high price, the composite vitamin trace element palm oil linseed oil nutritional edible oil and the manufacturing method thereof have the advantages that the linolenic acid content of the linseed oil is high, the resource is wide and the price is low, so the linseed oil is adopted to provide essential fatty acid linolenic acid which is necessary for maintaining the health, and the linseed oil with the linolenic acid content of more than 50 percent is used to improve the nutritional value and the commercial value of the palm oil with high yield and low price and only containing 0.4 percent of the linolenic acid. The linoleic acid content of the linseed oil is 15 percent, the linoleic acid content of the palm oil is 12 percent, and the linoleic acid content of the linseed oil and the linoleic acid content of the palm oil are basically balanced, so that the nutrition and the commercial value of the palm oil can be improved no matter the linseed oil is used together with the palm oil in any proportion, and the transformation, absorption and utilization of the linolenic acid cannot be influenced by the aforementioned enzyme competition; most importantly, the linolenic acid content of the scheme and the product thereof is far higher than that of common edible oil, so that the linolenic acid content of the scheme and the product thereof can be prepared into health-care products such as capsules for eating, and the nutritional value and the health-care effect and value of the ingested common edible oil can be improved by times; the carotenoids of palm oil enhance the nutritional value of linseed oil, and the vitamin trace elements enhance the nutritional and commercial values of linolenic acid oil and palm oil, as described in detail below.
The invention content is as follows: the palm oil and linseed oil nutrient oil serving as both medicine and food composite vitamin and trace elements consists of fat-soluble composite vitamin, fat-soluble composite trace elements, palm oil and linseed oil; the compound vitamin consists of fat-soluble vitamin A and fat-soluble vitamin D; the dosage of the fat-soluble vitamin A and the dosage of the fat-soluble vitamin D of the compound vitamin are respectively 3 to 6 parts and 0.05 to 0.15 part; the composite trace elements consist of soluble inorganic compounds of trace elements selenium, zinc and copper, composite emulsifier modified soybean phospholipid and glycerin monostearate to form water-fat compatible soluble composite trace elements; the raw material dosage of the trace element selenium, zinc and copper of the compound trace element is 0.1 to 0.3 portion of soluble inorganic selenium agent, 1 to 3 portions of soluble inorganic zinc agent and 1 to 3 portions of soluble inorganic copper agent according to the weight ratio, and the raw material dosage is calculated by the zinc, the copper and the selenium element contained in the raw material; the dosage of the compound emulsifier modified soybean phospholipid and the glyceryl monostearate is 1: 1 part by weight.
A manufacturing method of a composite vitamin microelement palm oil and linseed oil nutritional oil used as medicine and food comprises the following steps:
the preparation method of the compound vitamin comprises the following steps: in a sterile room, respectively adding 3-6 parts of vitamin A and 0.05-0.15 part of vitamin D which are approved by the national standard 2760 and are more than food grade into a stainless steel container with a stirrer, and stirring at a constant speed of 60-120 rpm for 2-3 minutes to obtain the fat-soluble composite vitamin; the preparation method of the water-fat soluble composite trace element comprises the following steps: in a sterile room, 0.1-0.3 part of soluble inorganic selenium agent, 1-3 parts of soluble inorganic zinc agent and 1-3 parts of soluble inorganic copper agent which are approved by the national standard 2760 and are more than food grade are respectively taken, and the modified soybean phospholipid and the glyceryl monostearate are respectively added into a mortar made of nonmetal materials for grinding to obtain the water-fat-soluble composite trace element for later use, wherein the parts are respectively calculated according to the selenium-zinc-copper element contained in the soluble inorganic copper agent and 1 part of the modified soybean phospholipid and the glyceryl monostearate. A manufacturing method of a compound vitamin microelement palm oil and linseed oil nutritional oil used as medicine and food is characterized in that: in a sterile room, taking 30-50 parts of palm oil, 30-50 parts of linseed oil and 0.1-1 part of fat-soluble vitamin complex according to the weight ratio, adding the mixture into a stainless steel container with a stirrer, stirring at a constant speed of 60-120 r/min for 2-3 minutes, fully dissolving and mixing uniformly for standby, taking 0.5-1 part of compound trace element with water and fat compatibility according to the weight ratio, adding the mixture into a mortar made of nonmetal materials, adding sterile water into the solution to dissolve the solution into a saturated solution, adding the solution into the standby solution, stirring at a constant speed of 60-120 r/min for 2-3 minutes, fully dissolving and mixing uniformly to obtain the compound vitamin trace element nutritional type edible oil raw oil, removing water below 0.2% specified by GB-edible vegetable oil according to a heating and dewatering method, performing an inspection method according to GB/5528 of the national standard, filling according to different weight or volume specification components, the palm oil and linseed oil nutritional edible oil product containing the composite vitamin and trace elements is obtained.
The edible and medicinal composite vitamin microelement palm oil and linseed oil nutritional oil is used as a food additive, is not limited in dosage and is used according to the normal production requirement; the edible oil is directly eaten, the daily intake of people under the age of 14 is 3-5 g, the daily intake of people above the age of 14 is 5-10 g, the edible oil is eaten for 2-3 times every day, and the maximum daily intake is 20-30 g, namely the daily edible oil eating amount recommended by WHO, so that the nutritional oil is recommended to replace the daily edible oil, and the excellent health-care effect of preventing and treating various diseases is achieved.
The main principles and advantages of the invention are as follows:
among the fat-soluble vitamins, vitamin A, D, E and carotenoids are fat-soluble vitamins which are easily deficient in the human body. The vegetable oil contains vitamin E, and has effects of increasing skin elasticity, caring skin, resisting oxidation, preventing hemolytic unsaturated fatty acid in erythrocyte membrane, preventing and treating nutritional megaloblastic anemia, improving reproductive function, preventing and treating acute liver cirrhosis, reducing blood lipid, softening blood vessel, preventing and treating cardiovascular and cerebrovascular diseases, and improving immunity and resistance; palm oil is also rich in carotenoids. When vitamin A in the body is deficient, the carotenoid can be automatically converted into the vitamin A in the body, and when the vitamin A is not deficient, the carotenoid is stored in fat in the body for later use, and the carotenoid is nontoxic, so that the national standard GB 2760-food additive is specified by the sanitary standard and used for all foods, and the dosage is used in a proper amount according to the production requirement, namely, the carotenoid is very safe without dosage limitation; vitamin A maintains the health of all epithelial tissues, particularly vascular endothelial cells phagocytize foreign matters, pathogenic viruses, necrotic and aged tissues, participates in collective immune activities including controlling blood pressure, thrombus, arteriosclerosis, angiogenesis, inflammation and filtration such as cerebral vascular barrier, and the epithelium of eyes, respiratory tracts, digestive tracts, intestinal tracts and urinary tracts, namely reproductive systems and the like is most seriously affected when vitamin A is deficient, which is obviously beneficial to the invasion of pathogenic viruses such as new crown viruses and the like from the epithelium and the vascular endothelial cells to comprehensively infect and aggravate the exacerbation of inflammatory reaction, and the detailed description shows that the vitamin A also has excellent beauty and health care effects of preventing and treating dry skin and hair loss, promoting normal growth and development, and causing reproductive function reduction, bone growth badness and growth retardation development when the vitamin A is deficient; vitamin A blocks cancer progression to reverse cancer, eliminates cancer stem cells to prevent and treat cancer such as increasingly recurrent and metastatic colon cancer, which is a main factor of cancer patient death, so vitamin A has good cancer prevention and treatment effects. Vitamin D has been used only as a medicine for the prevention and treatment of osteomalacia and rickets, researchers have recently found that higher blood vitamin D levels in cancer patients correlate with significantly improved survival and remission rates and are predictive of survival in a variety of cancer patients including colorectal, breast, lymphoma, lung, gastric, prostate, leukemia, melanoma, Merkel cell carcinoma, pancreatic cancer, etc., as evidence strongly supports the protective effects of high levels of vitamin D, such as a decrease in cancer incidence with an increase in vitamin D levels, e.g., a 67% lower risk of cancer in women with vitamin D levels of 40ng/ml or higher than in women with vitamin D levels of 20ng/ml or lower! The invention adopts the vitamin D to greatly improve the nutrition, medical care efficacy and commercial value of the edible oil, is superior to the VA edible oil which is only added with VA and is nutrient-reinforced by GB/T21123, and well solves the world historical problem.
The animal and vegetable oil and fat basically does not contain the beneficial trace elements selenium, zinc and copper which are easy to be lacked by the human body, and naturally does not meet the daily required amount of the human body. These vitamins and trace elements are very important and indispensable for human health, but daily food is difficult to satisfy daily requirement of human body and needs to be compensated, and various health problems such as sub-health and various serious diseases are caused, for example, copper has excellent and rapid (within 2-4 hours) killing and disintegration action and efficacy for various germs and viruses causing various diseases, especially for new crown virus, but daily food contains almost no copper and needs to be compensated in time, edible oil is almost consumed by anyone every day and even every meal, any other food can not be done, and industrialization and commodity rate of edible oil are extremely high, a study conductor 6-2-day-long leads to expert and scholars, which says that the people's life safety and body health are kept in the first place, and a strong public health system is established by the initiative, and obviously the food safety and health are the root and platform of the system naturally, edible oils, as such, represent valuable scarce public health system resources and should be mobilized and used as an excellent carrier and platform for extremely effective compensation of these easily scarce and important vitamins and trace elements. The efficacy of trace elements in the present invention is described in detail below.
The linseed oil contains 45-60% of linolenic acid, 15-30% of linoleic acid, 13-29% of oleic acid and 9-11% of saturated fatty acid, and has poor taste due to special smell; palm oil is widely applied to the fields of food (more than 5000 years of edible history), chemical industry and the like, the yield accounts for more than half of the total world vegetable oil trade, the production areas are only concentrated in malaysia, indonesia and nigeria, the total yield of the three countries accounts for 88 percent of the total world palm oil yield, but the trade and the consumption are global and are important components of the world oil market: the global oil market is mainly dominated by four crops, namely soybean oil, palm oil, sunflower seed oil and rapeseed oil, wherein in the oil, the vegetable oil accounts for 82% of the total amount of the whole oil, and the rest is composed of butter, lard, beef tallow, fish oil and the like. In recent years, the oil yield is generally increased continuously, but the animal oil yield is basically maintained unchanged, the oil yield is mainly increased from vegetable oil, and the palm oil in all vegetable oil is increased most obviously, for example, China is one of palm oil import and consumption countries, related enterprises and organizations are numerous, and the import and consumption are increased in recent years, so that the historical problem of improving the nutrition and commercial value of palm oil is very important and necessary naturally; the oil palm fruit contains two different kinds of oil, the palm oil is obtained from the pulp, the palm kernel oil is obtained from the palm seed (kernel), the oil palm is slightly sweet and has pleasant violet fragrance, the oil palm fruit is deep orange red due to the rich carotene with high nutritive value, and the consistency and the melting point of the oil palm fruit depend on the content of free fatty acid to a great extent, and the two kinds of oil are more important but are effectively applied to the fields of food, chemical industry and the like; palm oil is also called "saturated fat" because it contains 50% of saturated fat, and is a mixture of three components, saturated fat, monounsaturated fat, and polyunsaturated fat; the digestion and absorption rate of the human body to the palm oil is over 97 percent, and the palm oil does not contain cholesterol as all other vegetable edible oils; as grease and palm oil with higher saturation, the grease and palm oil with higher saturation are presumed to possibly increase the cholesterol content in human serum, but through further experimental demonstration of a plurality of experts, the edible palm oil is found not only not to increase the cholesterol in the serum but also has the trend of reducing the cholesterol, because a large amount of research data show that different saturated fatty acids have different influences on blood fat, the palm oil is rich in neutral fatty acids, substances for promoting the increase of the cholesterol have very little content and less than 1 percent content in the palm oil, the palm oil is rich in natural vitamin E and tocotrienol 600-, the linseed oil makes up the serious nutritional defect that the palm oil does not contain linolenic acid, so that the two components are mutually used for making up for the deficiency and overcoming the respective disadvantages and the advantages are complementary. Several researchers have conducted separate studies on different races (europe, america, asia) and have shown that palm oil is an edible vegetable oil that fully meets the needs of human health. Although the linoleic acid content of the palm oil is low, the combined balance and complementary maintenance capability and efficacy of the fat components such as cholesterol and the like of the palm oil compensate the defect of low linoleic acid content to a certain extent, namely, the linoleic acid content is improved, so that the specially designed invention scheme of combining the palm oil and the linseed oil obviously improves and greatly improves the series of defects compared with the single edible nutrient component, the nutrient value and the nutrient efficacy, and therefore, the series of worldwide problems of the palm oil and the single vegetable oil, such as resource protection, reasonable utilization and guarantee, low price, low cost and the like, are solved, and for example, the linolenic acid source with very high linseed oil can replace deep sea fish oil, so that marine fish resources and marine ecological environment are saved and protected. Linolenic acid has the normal structure and function of epithelial tissues such as brain, nerve and retina which are proved by experiments besides the series of medical effects, can relax blood vessels and inhibit platelet aggregation due to the reduction of the generation of active eicosanes, has multiple biological effects such as blood rheology, anti-inflammation, anti-tumor and the like due to epidemiological research, and proves that most of cholesterol in vivo is synthesized by liver and stored in gall bladder, such as coronary heart disease, cerebral infarction and the like due to accumulation on narrow coronary artery vessel wall, and has the advantages that the recurrence of coronary heart disease cannot be relieved even if the cholesterol in vivo and in vitro, namely in food, is absolutely reduced because the cholesterol is fat-soluble substance and cannot be dissolved in the water of blood, and the linolenic acid can dissolve and help to metabolize the fat in vivo and in the artery and the cholesterol, Especially old fat and cholesterol which can not be dissolved in blood (water) and can not be removed, so that the cholesterol can reverse harmful substances such as old fat and cholesterol accumulated on the inner wall of a human body, especially a blood vessel, greatly increase the inner diameter and elasticity of the blood vessel, improve the blood supply capability, reduce the blood pressure, prevent and treat thrombus and other important medical health care functions, and linolenic acid not only has the anti-cancer and anti-angiosclerosis effects, but also can automatically maintain, balance and adjust the quantity and the functions of the cholesterol, and provides new cholesterol for maintaining the normal structure and the functions of systems such as brain, nerves and the like while removing the old fat and cholesterol plaques and the harm and risk thereof. In conclusion, it is obvious that the blending oil formed by combining the palm oil and the linseed oil has a series of significant advantages, namely innovativeness identified by patent laws and inspection guidelines, and particularly has a series of advantages such as complementation of advantages and disadvantages of the blending oil and improvement of nutritional and medical care values and commercial values brought by the blending oil.
Selenium in vivo enables a water-soluble antioxidant to be combined with protein to protect an anti-peroxidation damage mechanism of a cell membrane and promote an oxidative phosphorylation process of energy metabolism, edible oil in China mainly comprises vegetable oil, the vegetable oil such as soybean oil which is large and most in consumption is an oxidation load agent, the edible oil inhibits the activity of enzymes such as selenium-containing glutathione peroxidase, the defense mechanism of an anti-peroxidation system of the cell membrane is reduced, the energy metabolism process is disordered, the long-term consumption of the soybean oil causes double obstruction of selenium absorption and utilization, and the double obstruction of serum selenium and red cell selenium content is reduced, so that a potential selenium deficiency state can be generated after the long-term consumption of soybean oil obstructs the selenium absorption and reduces the activity of the selenium-containing enzyme, and the wide region in China is a low-selenium region, and a large number of people in the selenium deficiency state are in the local area, therefore, enough attention is paid to and effective solution to the problem that the selenium deficiency in the body is possibly caused by long-term consumption of vegetable oil, particularly soybean oil. Selenium is an indispensable trace element in human bodies, and is easy to lack due to low content of food like zinc, and the Chinese nutritional society ranks selenium as one of 15 nutrients necessary for human bodies. 40 countries in the world are in selenium-deficient areas, China is a country with serious selenium deficiency, 70% of areas lack selenium, and hundreds of millions of people in 22 provinces are in selenium-deficient or low-selenium areas, and the incidence of tumors, liver diseases, cardiovascular diseases and the like of the population in the areas is high, so that scientific and orderly selenium supplement is urgent for residents in China to improve the dietary structure. The selenium is called as ' fire of life ' by scientists, the cancer of human beings, cardiovascular and cerebrovascular diseases, children's mental retardation, senile dementia, energy deficiency malnutrition, blood soluble anemia, keshan disease, Kashin-Beck disease, hypertension, ischemic heart disease, cirrhosis, pancreatitis, male infertility, female infecundity, diabetes, cataract, thyroid and prostate diseases and other 42 diseases are related to selenium deficiency, the selenium and heavy metal generate chemical reaction to remove toxic and harmful effects and protect people from the invasion of toxic carcinogens such as heavy metal and the like, the selenium greatly lightens the toxic and side effects and drug resistance of radiotherapy and chemotherapy, so that tumor cells are always sensitive to chemotherapy and easy to treat, the selenium is used as an antidote, the dosage of the chemotherapy drugs can be increased, the chemotherapy drugs can be used for a long time, and the potency is greatly improved. Selenium deficiency in humans leads to a decrease in body function, especially when highly pathogenic diseases such as various coronary viral diseases and natural infection with new coronary pneumonia are also increased, whereas the elderly have been able to recover their immunity to young people 6 months after taking an enzyme preparation containing 100 micrograms of selenium per day. In the case of selenium deficiency, the pathogenicity of the virus is enhanced. For example, enterovirus-Coxsackievirus-Coxsackie virus, which is an enterovirus that is apt to cause pneumonia and enteritis in cold patients, scientists have isolated Coxsackie virus from blood and tissues of patients suffering from Kanshima and confirmed that Kanshima is caused by the virulent Coxsackie virus, and globally recognized new coronavirus is also found in the intestines of infected persons, and the infected persons also have gastrointestinal discomfort such as abdominal pain and diarrhea, i.e., "abdominal cold", one or two days earlier than pneumonia, indicating that the new coronavirus invades and infects the stomach and intestine first. These suggest that selenium may also have excellent attenuation, control, and therapeutic effects on enteroviruses, i.e., new coronaviruses and pneumonia thereof, and that other viruses, such as common cold virus, aids virus, ebola virus, smallpox virus, and hepatitis virus, have similar sensitivity to selenium. For example, the mortality rate of AIDS patients without selenium deficiency is 1/20 times that of AIDS patients without selenium deficiency, namely, the mortality rate of AIDS patients without selenium deficiency is more than 20 times that of AIDS patients without selenium deficiency. Selenium against cancer and coronavirus is therefore particularly desirable for research. The selenium supplement of the selenium supplement is more than 25 micrograms per day for adults in China, and the selenium supplement of the selenium supplement is 50 micrograms or more than 75 micrograms per day for the adults with selenium deficiency, so that the maximum tolerable intake is 400ug per day. Although many health products contain selenium, the content is too low and expensive, and other ingredients which are not deficient in human body are also contained, so the product of the present invention is safe and effective for supplementing selenium.
Zinc is distributed in all organs and blood of human body, and the content of zinc in bones, eyeballs and skin is the largest. Zinc affects the structure and function of the nervous system, as well as the regulation of various enzymes and receptor functions, is closely related to vitamin A metabolism, DNA, RNA and protein biosynthesis, and to the normal functions of pancreas, gonads, pituitary gland, digestive system and skin. Zinc deficiency causes decreased emotional stability, impaired immune function and intelligence such as decreased learning ability and performance, oral ulcers, male and female infertility, decreased appetite, digestion and immune function, diarrhea and cold, growth and development retardation, rare and yellow hair, oral ulcers, slow wound healing, inflammation of the intestinal tract and respiratory tract and easy recurrence, which is apparently susceptible to various infectious diseases such as coronavirus, e.g., new corona virus, influenza virus, etc., with serious consequences. Zinc is closely related to diabetes, the serum zinc concentration of a diabetic patient is very low, the loss of zinc in urine is increased, and the blood zinc concentration is inversely related to the degree of diabetes, namely, the zinc supplement directly prevents and treats the diabetes and reduces the degree of damage thereof, such as obviously reducing the death rate of zinc vascular disease of the diabetes and the blood sugar, namely the cholesterol level and the damage thereof. Zinc also has effects of scavenging free radicals and other harmful substances, and resisting cancer, radiation and aging. The vegetable food contains 1 mg of zinc per 100 g of vegetable food, 3-5 mg of zinc per 100 g of animal food, and is mainly in viscera, but people have fear that toxic substances such as heavy metal in viscera are high and accumulated, and rarely eat the viscera in normal times, even if people eat the viscera every day and reach 100 g of zinc, the vegetable food contains very low zinc, only 1 mg of zinc per hundred g, fruits contain minimum zinc, and only 0.2 mg of zinc per hundred g, namely common food is zinc-deficient food, and the digestion and absorption rate is lost. While each person over 1 year of age needs 10-15 mg of zinc per day, obviously needs additional supplementation. The mineral water national standard zinc limit index bottom line is not less than 0.2 mg and 200 micrograms/liter, and has no limit index, which indicates that zinc has little harm to human bodies and is not easy to exceed the standard, but is easy to greatly lack, because few people, especially children can eat 1 kilogram of vegetables or half kilogram of meat every day for a long time. Adults tolerate a maximum intake of 45 mg daily, up to 80-400 mg to be toxic, and obviously the daily diet is not likely to consume excessive amounts of zinc at all.
The above-mentioned materials are mentioned as the significant effects and effects of copper in preventing and treating pestilence, especially coronavirus such as new crown, and the significant effects and effects are not described in detail herein. Besides, copper has the following series of important medical health-care effects: copper deficiency can cause nervous system disorder, pigment oxidase in brain cells is reduced in activity, cardiovascular diseases can cause coronary heart disease due to the fact that synthesis of metalloenzyme is reduced and normal form and function cannot be maintained, ceruloplasmin concentration is reduced to cause iron to be difficult to convert so as to induce anemia, copper-containing metallothionein, superoxide dismutase and the like have a strong function of clearing metabolic waste, human cells are protected from being damaged, cancer patients can be supplemented with copper to prevent cancer cell proliferation, women are difficult to conceive and abortion or fetal infection and congenital deficiency and congenital disability, children are short of copper and bone development is stopped so as to cause dwarfism, copper element can also prevent early-onset leukoderma and leucoderma, insomnia and cardiovascular diseases caused by excessive rise of blood cholesterol indexes due to copper deficiency, and particularly, the children are easy to lack of copper when being eaten. Copper participates in iron metabolism and erythropoiesis, copper-deficient anemia is caused by deficiency, the prevention and treatment can be realized only by supplementing copper, the copper promotes normal formation of melanin and maintains the normal structure of hair, cells are protected from being damaged by superoxide anions, and the reduction of blood sugar and the obvious improvement of the state of illness of diabetes patients who are ineffective in conventional treatment are treated by copper ions. Copper is seen to play a significant role in anti-aging. The daily copper requirement of human body is about 2 mg and can be tolerated by 8 mg/day, the copper is mainly existed in grain embryo bud and animal viscera, the daily food does not contain the food basically and is easy to cause copper deficiency, the absorption of the copper is regulated by the copper requirement of the body, the excessive copper in the body, namely endogenous copper, can be excreted to gastrointestinal tract in a 'retrograde' way and is discharged out of the body along with the excrement, and the daily food has extremely low copper content and the absorption rate difference is only about 40 percent, and the copper needs to be supplemented.
The characteristics and the characteristics of the traditional Chinese medicine are preventive, so the theory of macroscopically preventing and treating the disease of the traditional Chinese medicine, namely the integral disease prevention and treatment theory, and the theory of preventing and treating the disease of the western medicine, namely different diseases and pathogenic reasons such as different pathogenic microorganisms one by one 'number-to-seat' are completely different, but the diseases can be prevented and treated, obviously, the theories are correct and cannot be denied mutually, but the theories need to combine the traditional Chinese medicine and the western medicine and mutually take the strong and strong combination of strong and strong reinforcement, which is the reason why the traditional Chinese medicine and the western medicine are combined and developed together, so the invention designs an invention scheme by taking the principle of combining the traditional Chinese medicine and the western medicine into consideration, and the invention is specifically explained in detail as above, so the invention is only briefly discussed as follows: the palm oil and the linseed oil are edible oil and traditional Chinese medicine, and the traditional Chinese medicine theory and the western medicine theory and practice consider that the palm oil and the linseed oil have the effects of moistening skin, relaxing bowel, preventing and treating constipation, diminishing inflammation, protecting the skin, clearing liver, benefiting eyes, protecting eyes, promoting lipolysis and other traditional Chinese medicine and western medicine curative effects, for example, the essential fatty acid linoleic acid, especially linolenic acid, can dissolve old fat and cholesterol, namely blood vessel plaque, so as to prevent and treat serious harm and life health threatening series diseases such as hypertension, thrombus, cardiovascular and cerebrovascular diseases, for example, the new crown virus plague of the whole world of Matcha is only pneumonia and inflammatory storm diseases thereof, and the main cause of serious illness and death, but the reason cannot explain that serious and dead serious disaster areas are obese and overweight patients, and the latest article published by the Top-level medical journal of the world reveals that the new crown plague is not simple respiratory system disease, more particularly, the new coronavirus enters cells to be destroyed and replicated by using an egg called ACE2 receptor, which is widely present on vascular endothelial cells and fat cells in liver, kidney, heart and intestine, so that the main cause of infection and death of the new coronavirus, namely storm factor, is to comprehensively infect and destroy human organs, especially smokers and fat people, rather than only infecting and destroying lung functions. This explains why obese people and patients with hypertension, diabetes, obesity, cardiovascular and cerebrovascular diseases, etc. are people at high risk and poor prognosis of new coronary infection, because their vascular endothelial cells are more easily attacked by viruses and induce severe inflammatory reactions and thrombosis, etc., which result in the lungs being bloodless and unable to exchange gas naturally and suffocate to die, even if the upper respirator is used under the condition of extensive and serious thrombus in the pulmonary vessel and obstructed asphyxia, the upper respirator can not play a role in assisting breathing and saving life at all, and is only arranged with high price, this is the main reason why the essentially ineffective mortality rate for ventilator rescue is extremely high for critically ill new coronary patients, so that the severe patients and the deaths of the new coronavirus plague and the causes and causes of the new coronavirus plague are not actually pneumonia and inflammatory factor storm only, but more importantly, the thrombus is dead, and the true "I cannot breath I! The essential fatty acid explained above is dissolved, diluted and transported away along with the blood flow circulation and metabolized to generate the plaque-like polymeric substance which causes thrombus, the aggregation and falling or rupture of the plaque-like polymeric substance to resist thrombus, the linolenic acid explained below and the like to prevent and reduce inflammatory reaction, enhance liver and kidney functions and resist new coronavirus plague inflammatory storm, and the like, the latest scientific and technical knowledge and examination guidelines in the field do not need experimental proof and innovative regulation about the effects which can be met and deduced according to common knowledge, and the invention proves that the nutritional support anti-inflammatory storm scheme of linolenic acid and linoleic acid up to 3: 1 and the like and the product necessarily have excellent effects of preventing and treating new coronavirus plague without experiments; the phospholipid and choline of the soybean phospholipid help liver transportation and fat metabolism to prevent and treat fatty liver, clear liver and improve eyesight, and because the liver belongs to the liver, the liver is healthy and clear, the liver is most prone to inflammation such as hepatitis, and once the liver is cured, the liver is difficult to cure or even is not cured for a long time, the metabolic capability of the fat is greatly reduced to cause obesity, while the obesity and the diabetes (the cause of the obesity is also caused by the obesity) are prone to generate a large amount of inflammatory factors in vivo, and the 'inflammatory factor storm' with extremely high mortality rate is more easily generated when the patient suffers from the disease, for example, the obesity of a new crown virus plague infected person, the severe rate and the mortality rate of the patient with the diabetes are obviously high; the essential fatty acid linoleic acid is too abundant to generate and increase inflammatory reaction, because it produces a large amount of arachidonic acid converted into proinflammatory lipid mediators, unfortunately it has been mentioned that just linoleic acid content in the daily edible oil is too high, but linolenic acid can prevent and reduce inflammatory reaction, because it can reduce the activity of desaturase to reduce the yield of arachidonic acid, and can also inhibit the conversion of arachidonic acid into proinflammatory lipid mediators; it has been mentioned that the ratio of linoleic acid to linolenic acid in the daily edible oil is preferably 1: 1, and the ratio is preferably 4-6: 1 suggested by WHO, whereas linoleic acid to linolenic acid in the daily edible oil is 10: 1, even 25-30: 1, i.e. linoleic acid is more than ten times higher and linolenic acid is more than ten times lower, which is the reason why the inflammatory reaction is more serious as more oil is taken daily, and once the body suffers from internal and external injuries, linoleic acid inevitably causes and aggravates the inflammatory reaction, such as common frequently-occurring neck, chest, lumbar disc herniation and scapulohumeral periarthritis, which can not be cured for a long time and is more serious as time goes on, even if the body is concerned, the disease is relieved in a half year, which is the reason that the disease of 'fifty shoulder and sixty shoulder' is cured for at least half a year or even for one year and longer, and the treatment is basically ineffective because the disease is aseptic inflammation, therefore, all antibacterial and antiviral drugs are totally ineffective, namely, no medicine can replace or substitute the anti-inflammatory factor efficacy of the linolenic acid, which explains why the fact that the disease caused by the deficiency of essential fatty acid can be prevented and controlled only by the essential fatty acid is emphasized at the beginning, and people do not realize the specific and special prevention and control efficacy of the linolenic acid and fail to eat the linolenic acid to prevent and control the diseases is not conjectured, but is verified by the fact that the inventor uses the linolenic acid to cure a plurality of patients such as scapulohumeral periarthritis for many years; because of the anti-inflammatory factor storm and antithrombotic effects of the nutrients such as linolenic acid, phospholipid, choline and the like, the synergistic complementary strengthening effect of the vitamins and trace elements of the invention, and the regulation of the latest scientific and technological knowledge and examination guidelines in the field, the product of the invention inevitably has excellent prevention and treatment effects on the global new coronavirus plague without experimental verification and innovation, the impotence is a common disease of men and is difficult to open teeth pain, and the factors of hypertension, obesity, diabetes, arteriosclerosis and endocrine are more, which are highly consistent and closely related with the etiology of other diseases prevented and treated by the invention, for example, except that the linolenic acid removes vascular plaques to improve the blood supply of penis to help to fill and straighten the blood and directly improve the impotence, the vitamin A improves the normal secretion function of testis, prostate and ovary such as estrogen, and the vitamin D leads the plasma calcium to reach the saturation degree, the calcium deficiency of the muscle can cause the impotence or weakness of ejaculatory muscles, cavernous body muscles and penis and clitoris erectile muscles and incapability of erection or permanent erection, namely impotence of men and women; the trace elements selenium and zinc activate more than one hundred enzyme activities, and the acknowledged and proven facts prove that the selenium and zinc have excellent effects of preventing and treating cancers, obesity, diabetes, cardiovascular and cerebrovascular system diseases and the like directly, so that the selenium and zinc also have excellent prevention and treatment functions on impotence caused by the diseases naturally; the product of the invention is made into capsules, which is more convenient to carry and take, thus improving beneficial people such as huge mobile people such as huge tourism and business trip people, the types and the efficacy of the disease prevention and treatment are far better than GB/T21123 nutrition-enriched VA edible oil only added with VA, the product accords with the national policy of the habit chairman, provides powerful guarantee for the health of people, promotes the complementary development of Chinese and western medicines and great national policy of nutrient oil, because the formula and the raw materials designed by the invention are not only edible and medicinal products, but also are Chinese medicines and western medicines, for example, the vitamin A, D is natural substance components of the nature of animals and plants, namely belongs to the Chinese medicine, and can be synthesized to belong to the western medicine; the trace elements selenium, zinc and copper are natural substances, are also derived from natural minerals, belong to the field of traditional Chinese medicine, and are also compounds produced by human beings, such as selenium dioxide, sodium selenate, sodium selenite, copper sulfate and zinc sulfate, belong to western medicine.
The purpose and the technical scheme as well as the series of significant outstanding advantages thereof and the innovativeness identified by patent methods and examination guidelines are realized by the comprehensive scheme, the method also innovatively utilizes the emulsifier to uniformly and stably distribute water-insoluble trace elements in the oil, and innovatively screens the nutrient which is not only the emulsifier but also a nutrient, is also necessary for fat metabolism and is easy to be lacked by a human body, such as soybean lecithin, and rich choline cholamine cephalin lecithin and the like which are contained in the soybean lecithin are all nutrient substances for promoting the oil metabolism to prevent and treat common diseases such as obesity, fatty liver, diabetes and the like, and improves the physiological effects of essential fatty acids, particularly linolenic acid, which are equivalent to increase of linolenic acid resources with rare and expensive resources; in addition, the emulsifying effect shared by the two emulsifiers is the multiplication effect of a single emulsifier, so that composite trace elements insoluble in oil are more uniformly and stably distributed in the oil to ensure the uniform and stable product quality, the integral manufacturing is simple and easy in process, equipment and factory buildings are small in investment cost, high in input-output ratio, high-quality and low in price, and the product is high-quality nutritional edible oil with series nutritional effects and has strong competitiveness, for example, the national standard nutritional oil only strengthens vitamin A, so that the product is more nutritional and comprehensive than the national standard nutritional oil, and has the advantages of no environmental pollution, no water consumption, low energy consumption and the like.
Example (b):
in a sterile room, respectively adding 5 parts of vitamin A and 0.1 part of vitamin D which are approved by the national standard 2760 and are more than food grade into a stainless steel container with a stirrer according to the weight ratio, and stirring at a rotating speed of 80 rpm for 2 minutes at a constant speed for later use to obtain the fat-soluble composite vitamin; respectively taking 0.2 part of sodium selenite, 2 parts of zinc sulfate and 2 parts of copper sulfate in a sterile room, adding 1 part of modified soybean phospholipid and 1 part of glyceryl monostearate in terms of selenium, zinc and copper elements into a mortar made of a non-metal material, and grinding to obtain water-fat soluble composite trace elements for later use; in a sterile room, taking 30 parts of palm oil, 50 parts of linseed oil and 0.5 part of fat-soluble composite vitamin according to the weight ratio, adding the mixture into a stainless steel container with a stirrer, stirring at a rotating speed of 60 r/min for 3 minutes, fully dissolving and uniformly mixing, taking 1 part of fat-compatible composite trace element according to the weight ratio, adding the mixture into a mortar made of non-metal materials, adding sterile water to dissolve the mixture into a saturated solution, adding the saturated solution into a standby solution, stirring at a constant speed of 100 revolutions per minute for 3 minutes, fully dissolving and uniformly mixing to obtain raw oil of the composite vitamin microelement nutritional oil for medicine and food, removing water by a conventional vegetable oil heating and water removing method to ensure that the water content is below 0.2 percent specified in GB-edible vegetable oil, performing a test method according to GB/T5528, and packaging according to 0.5-1ml per capsule to obtain the composite vitamin microelement palm oil and linseed oil nutritional oil capsule product for medicine and food. The capsule is administered by children under 10 years old at a dose of 0.5 ml/capsule to ensure safety.
Particularly, it is stated that: the above embodiments are merely examples of the production of a capsule, and the present invention is not limited to the above embodiments.
Claims (9)
1. The palm oil and linseed oil nutrient oil as both medicine and food as a composite vitamin is characterized by consisting of fat-soluble composite vitamin, fat-soluble composite trace elements, palm oil and linseed oil.
2. The palm oil and linseed oil nutrient oil as a medicine and food dual-purpose compound vitamin microelement is characterized in that compound vitamin consists of fat-soluble vitamin A and fat-soluble vitamin D.
3. The palm oil and linseed oil nutrient oil as both medicine and food as a composite vitamin microelement is characterized in that the dosage of fat-soluble vitamin A and the dosage of fat-soluble vitamin D of the composite vitamin are respectively 3-6 parts and 0.05-0.15 part.
4. The palm oil and linseed oil nutritious oil as one kind of medicine and food material features its composite trace elements comprising soluble inorganic compounds of trace elements Se, Zn and Cu and composite emulsifier.
5. The palm oil and linseed oil nutrient oil as a medicine and food dual-purpose compound trace element is characterized in that the raw materials of trace elements selenium, zinc and copper of the compound trace element are as follows by weight: 0.1-0.3 part of soluble inorganic selenium agent, 1-3 parts of soluble inorganic zinc agent and 1-3 parts of soluble inorganic copper agent, wherein the raw materials of the composite emulsifier comprise 1: 1 part of modified soybean phospholipid and glyceryl monostearate according to the weight ratio based on zinc, copper and selenium elements contained in the composite emulsifier.
6. A manufacturing method of a composite vitamin microelement palm oil and linseed oil nutritional oil used as medicine and food is characterized in that the manufacturing method of the composite vitamin comprises the following steps: in a sterile room, respectively adding 3-6 parts of vitamin A and 0.05-0.15 part of vitamin D which are approved by the national standard 2760 and are above food grade into a stainless steel container with a stirrer, and uniformly stirring at a rotating speed of 60-120 rpm for 2-3 minutes for later use to obtain the fat-soluble composite vitamin.
7. A manufacturing method of a composite vitamin microelement palm oil and linseed oil nutrient oil used as medicine and food is characterized in that the manufacturing method of the composite microelement comprises the following steps: in a sterile room, 0.1-0.3 part of soluble inorganic selenium agent, 1-3 parts of soluble inorganic zinc agent and 1-3 parts of soluble inorganic copper agent which are approved by the national standard 2760 and are more than food grade are respectively taken, and the modified soybean phospholipid and the glyceryl monostearate are respectively added into a mortar made of nonmetal materials and ground to obtain the water-fat-soluble composite trace element for later use, wherein the parts are calculated according to the elements of selenium, zinc and copper.
8. A manufacturing method of a compound vitamin microelement palm oil and linseed oil nutritional oil used as medicine and food is characterized in that: in a sterile room, taking 30-50 parts of palm oil, 30-50 parts of linseed oil and 0.1-1 part of fat-soluble vitamin complex according to the weight ratio, adding the mixture into a stainless steel container with a stirrer, stirring at a rotating speed of 60-120 r/min for 2-3 minutes to be fully dissolved and mixed, taking 0.5-1 part of compound trace element with water-fat compatibility according to the weight ratio, adding the mixture into a mortar made of nonmetal materials, adding sterile water to be dissolved into saturated solution, adding the saturated solution into a standby solution, stirring at a rotating speed of 60-120 r/min for 2-3 minutes to be fully dissolved and mixed to obtain the compound vitamin trace element nutritional type edible oil raw oil, removing water below the water content specified by the national standard GB-edible vegetable oil according to a conventional vegetable oil heating and water removal method, performing the inspection method according to the national standard GB/55T 28, filling into bottles and/or capsules according to different weight or volume specification components to obtain the composite vitamin microelement palm oil and linseed oil nutritional edible oil product.
9. The application of the composite vitamin microelement palm oil and linseed oil nutritional oil used as medicine and food is characterized in that: the product is used as food additive, the dosage is not limited, and the product can be used according to the normal production requirement; the food is directly eaten, wherein the daily intake of people under 14 years old is 3-5 g, the daily intake of people above 14 years old is 5-10 g, the food is eaten by 2-3 times every day, and the maximum daily intake is 20-30 g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010539741.2A CN111631404A (en) | 2020-06-12 | 2020-06-12 | Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010539741.2A CN111631404A (en) | 2020-06-12 | 2020-06-12 | Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111631404A true CN111631404A (en) | 2020-09-08 |
Family
ID=72323896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010539741.2A Pending CN111631404A (en) | 2020-06-12 | 2020-06-12 | Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111631404A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403023A (en) * | 2002-08-05 | 2003-03-19 | 颜怀玮 | Fatty acid nutrient product with slimming, disease-resisting and antisenility functions and its production process |
CN1685974A (en) * | 2005-05-08 | 2005-10-26 | 颜怀玮 | Liposoluble composite vitamin microelement and nutritive edible oil product and manufacturing method |
CN1685902A (en) * | 2005-05-08 | 2005-10-26 | 颜怀玮 | Liposoluble composite vitamin micro element and essential fatty acid and nutritive type edible oil and manufacturing method |
CN101816342A (en) * | 2010-05-06 | 2010-09-01 | 陈阳清 | Compound intensified bi-functional edible oil for medicines and eating and manufacturing method thereof |
-
2020
- 2020-06-12 CN CN202010539741.2A patent/CN111631404A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403023A (en) * | 2002-08-05 | 2003-03-19 | 颜怀玮 | Fatty acid nutrient product with slimming, disease-resisting and antisenility functions and its production process |
CN1685974A (en) * | 2005-05-08 | 2005-10-26 | 颜怀玮 | Liposoluble composite vitamin microelement and nutritive edible oil product and manufacturing method |
CN1685902A (en) * | 2005-05-08 | 2005-10-26 | 颜怀玮 | Liposoluble composite vitamin micro element and essential fatty acid and nutritive type edible oil and manufacturing method |
CN101816342A (en) * | 2010-05-06 | 2010-09-01 | 陈阳清 | Compound intensified bi-functional edible oil for medicines and eating and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bhowmik et al. | A potential medicinal importance of zinc in human health and chronic | |
US7887847B2 (en) | Nutritional supplement for treatment of ocular diseases | |
CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN110226744A (en) | A kind of prostatitis tailored version clinical nutrition formula and preparation method thereof | |
CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
CN104336675A (en) | Black sesame and fructus lycii nutritious congee and preparation method | |
CN110583780A (en) | A solid beverage for preventing and reducing hypertension and hyperuricemia | |
CN103190483A (en) | Children growth promotion milk tea | |
CN111771988A (en) | Nutritional food suitable for diabetic patients and preparation method thereof | |
RU2665635C2 (en) | Multivitamin/mineral composition for controlling environmental stress effects; improving immunity and increasing activity, aiming at vitamin and mineral insufficiency with no negative side effects of mega-dosage food additive | |
CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
Mishra et al. | Importance of dietary supplements to the health | |
Singh et al. | Food nutrition, science and technology | |
CN108741086A (en) | A kind of sports tonica and preparation method thereof suitable for long-term body-building | |
CN108354177A (en) | Selenium-enriched scallop oral liquid with good selenium supplementing effect | |
CN109892495A (en) | A kind of selenium-rich, the production method of zinc and iron chicken feed and selenium-rich, zinc and iron egg | |
CN108851037A (en) | A kind of preparation method and its usage of nephrotic syndrome wholefood | |
CN111631404A (en) | Edible and medicinal composite vitamin microelement palm oil and linseed oil nutrient oil and preparation method thereof | |
CN110742266B (en) | Total nutrient formula food for assisting in regulating intestinal immunity function | |
US20040202732A1 (en) | Composition to promote weight loss | |
CN108371709A (en) | Lycium ruthenicum tumor recovering gene enzyme | |
CN102763845A (en) | Seabuckthorn fruit oil and propolis soft capsule | |
CN108851038A (en) | Diabetic complication nephrosis nutraceutical and preparation method thereof | |
TWM579033U (en) | Protein and peptide containing microparticle structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Chongqing Zhenminrun Technology Co.,Ltd. patent The person in charge Document name: Notice of first review opinion |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 402,160 No. 906, Honghe Road, Zhongshan Road Street, Yongchuan District, Chongqing Applicant after: Chongqing zhenminrun Technology Co.,Ltd. Address before: 402160 No.1, Floor 2, No. 203, Longxi Avenue, Da'an Street, Yongchuan District, Chongqing Applicant before: Chongqing zhenminrun Technology Co.,Ltd. |